McBride (LSE: MCB) shares rise as Eurotab and Vestacy reshape its FY27 growth outlook

McBride plc (LSE: MCB) has closed FY26 with lower earnings but a substantially different growth profile from the one investors were assessing when raw-material inflation forced the company to reset expectations earlier in the year. Revenue increased 0.8% to £934.2 million, while adjusted EBITDA declined 6.8% to £80.0 million and adjusted operating profit fell to £59.0 million. The weakness was concentrated around the lag between sharp Q4 input-cost inflation and customer price recovery, while private-label volumes still increased modestly.

McBride shares were around 192p during September 15 trading, approximately 3% higher on the session and roughly 9% below the 52-week high of 211.5p reached in late August. The positive reaction suggests investors were willing to look beyond the weaker FY26 profit comparison toward Eurotab, Vestacy and the prospect of renewed margin improvement.

How badly did Middle East-linked inflation affect McBride’s FY26 profitability?

Adjusted EBITDA declined from £85.8 million to £80.0 million, reducing the adjusted EBITDA margin from 9.3% to 8.6%. Adjusted profit before tax fell to £48.8 million from £54.9 million, while statutory profit before tax declined to £39.9 million from £49.0 million. Management attributed most of the pressure to the timing gap between higher Q4 raw-material and logistics costs and the price increases required to recover those costs from customers.

The pricing lag remains relevant at the start of FY27. McBride expects first-quarter margins to remain affected before improving during the second quarter, although further materials inflation could alter that timetable. The company has warned that geopolitical uncertainty continues to make the cost environment difficult to forecast and additional customer price increases may be required.

The underlying private-label demand picture remains more supportive. Group volumes were broadly stable and private-label volumes grew approximately 0.4%, partially offsetting weaker contract-manufacturing demand. That distinction matters because consumers trading toward cheaper retailer-owned cleaning products during periods of household inflation can support McBride volumes even while the same inflation hurts manufacturing margins.

How much does the Eurotab acquisition change McBride’s European cleaning portfolio?

McBride completed its acquisition of Eurotab Group on July 1 for consideration of €40.8 million including approximately €8 million of acquired cash, with €31.3 million relating to repayment of third-party debt. Eurotab operates two specialised manufacturing facilities in France and a smaller Turkish business, adding expertise in solid-format cleaning products.

The acquisition strengthens McBride’s exposure to tablets and unit-dose formats, broadening a portfolio historically weighted toward liquids, powders, aerosols and other private-label cleaning products. Management expects Eurotab to be earnings-per-share accretive from completion and said initial integration work has begun well.

The strategic value extends beyond acquired revenue. Solid-format detergents can command different manufacturing economics and give retailers additional alternatives to branded products, while McBride can potentially combine Eurotab’s capabilities with its wider customer relationships and purchasing scale. The success of the deal will ultimately be measured through synergies, capacity utilisation and cash returns rather than the acquisition headline alone.

Why could McBride’s Vestacy partnership be more important than the Eurotab deal?

The Vestacy partnership potentially creates a much larger step-change in group economics. Under multi-year agreements announced in August, McBride will manufacture a range of household products for Vestacy across Europe, with a particular focus on laundry, while acquiring dedicated production facilities in Spain and Portugal for nominal consideration. Vestacy is expected to finance new production equipment across McBride’s European network alongside targeted investment from McBride itself.

Management expects the partnership to increase group revenue and earnings by approximately 15% when it reaches maturity in early 2028. Applied simply against FY26 revenue of £934.2 million, a 15% uplift would imply more than £140 million of additional annual revenue, although actual future results will depend on the precise ramp-up, contract mix, pricing and performance of the wider group.

The capital structure makes the arrangement particularly attractive. Vestacy’s funding of new equipment reduces the amount McBride needs to invest itself while the acquired Iberian facilities provide dedicated manufacturing infrastructure. If execution proceeds according to plan, the partnership can increase scale without requiring a proportionate increase in McBride-funded capital expenditure.

Can McBride fund growth while continuing to return cash to shareholders?

McBride returned £18.0 million to shareholders and employees during FY26 through £5.2 million of dividends, £6.4 million of share buybacks and £6.4 million of Employee Benefit Trust share purchases that reduce future incentive-plan dilution. The board has recommended a 3.1p final dividend compared with 3.0p for FY25 and continues operating a buyback programme authorised for up to £20 million.

Debt has increased, however. Reported net debt rose to £122.8 million from £105.2 million, partly because McBride drew additional borrowing ahead of the Eurotab acquisition, while banking-basis leverage remained much lower at 0.6 times EBITDA after adjusting for invoice-discounting arrangements and other items defined under its credit facility. The group has a €240 million sustainability-linked revolving credit facility running to November 2029 and additional accordion capacity.

McBride is therefore simultaneously funding acquisitions, industrial investment, dividends and share repurchases. That is sustainable only if EBITDA and cash generation recover as management expects, making FY27 margin progression particularly important.

The longer-term attraction is clear. Eurotab expands product capability, Vestacy could add approximately 15% to revenue and earnings at maturity, and McBride’s transformation programme has already produced £15.3 million of cumulative net benefits toward a £50 million target by June 2028. If those initiatives push the adjusted EBITDA margin toward management’s 10% ambition, FY26 could eventually look like a temporary inflation setback rather than the end of the recovery.